![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/06/24/2903356/0/en/Beyond-Air-Reports-Fiscal-Fourth-Quarter-and-Full-Year-2024-Financial-Results-and-Provides-Corporate-Update.html
https://www.globenewswire.com/news-release/2024/05/23/2887643/0/en/Beyond-Air-Schedules-Fiscal-Year-End-2024-Financial-Results-Conference-Call-and-Webcast.html
https://www.globenewswire.com/news-release/2024/03/20/2849409/0/en/Beyond-Air-Announces-Pricing-of-16-0-Million-Registered-Direct-Offering-of-Common-Stock-and-Warrants.html
https://www.globenewswire.com//news-release/2024/02/12/2827860/0/en/Beyond-Air-Reports-Financial-Results-for-Third-Quarter-of-Fiscal-Year-2024.html
https://www.globenewswire.com//news-release/2024/01/18/2811468/0/en/Beyond-Air-Schedules-Third-Fiscal-Quarter-2024-Financial-Results-Conference-Call-and-Webcast.html
https://www.globenewswire.com//news-release/2023/12/27/2801322/0/en/Beyond-Cancer-Phase-1-Study-Clears-Cohort-1-in-Patients-with-Advanced-Relapsed-or-Refractory-Unresectable-Primary-or-Metastatic-Cutaneous-or-Subcutaneous-Solid-Tumors.html
https://www.globenewswire.com//news-release/2023/11/15/2781400/0/en/Beyond-Air-To-Participate-in-the-35th-Annual-Piper-Sandler-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2023/11/13/2779436/0/en/Beyond-Air-Reports-Financial-Results-for-Second-Quarter-of-Fiscal-Year-2024.html
https://www.globenewswire.com//news-release/2023/11/03/2773315/0/en/Beyond-Cancer-Presents-Positive-First-in-Human-Clinical-Data-for-Ultra-High-Concentration-Nitric-Oxide-UNO-Therapy-in-Solid-Tumors-During-the-Society-for-Immunotherapy-of-Cancer-SI.html
https://www.globenewswire.com//news-release/2023/10/19/2763669/0/en/Beyond-Air-Schedules-Second-Fiscal-Quarter-2024-Financial-Results-Conference-Call-and-Webcast.html